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The striatum is a key structure for movement control, but the mechanisms that dictate the
output of distinct subpopulations of medium spiny projection neurons (MSNs), striatoni-
gral projecting and dopamine D1 receptor- (D1+) or striatopallidal projecting and dopamine
D2 receptor- (D2+) expressing neurons, remains poorly understood. GABA-mediated tonic
inhibition largely controls neuronal excitability and action potential ﬁring rates, and we pre-
viously suggested with pharmacological analysis that the GABAA receptor β3 subunit plays
a large role in the basal tonic current seen in D2+ MSNs from young mice (Ade et al.,
2008; Janssen et al., 2009). In this study, we demonstrated the essential role of the β3
GABAA receptor subunit in mediating MSN tonic currents using conditional β3 subunit
knock-out (β3f/fDrd2) mice. Cre-lox genetics were used to generate mice where Cre recom-
binase was expressed under the D2 receptor (Drd2) promoter. We show that while the
wild-type MSN tonic current pattern demonstrates a high degree of variability, tonic cur-
rent patterns from β3f/fDrd2 mice are narrow, suggesting that the β3 subunit is essential
to striatal MSN GABA-mediated tonic current. Our data also suggest that a distinct popu-
lation of synaptic receptors upregulate due to β3 subunit removal. Further, deletion of this
subunit signiﬁcantly decreases the D2+ MSN excitability. These results offer insight for
target mechanisms in Parkinson’s disease, where symptoms arise due to the imbalance in
striatal D1 and D2 MSN excitability and output.+ +
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INTRODUCTION
Medium spiny neurons (MSNs) are GABAergic projection neu-
rons of the striatum, and project either to the substantia nigra pars
reticulata though a direct pathway or the globus pallidus through
an indirect pathway (Gerfen et al., 1990). MSNs of the direct path-
way express the dopamine D1 receptors (D1+); their activity is
thought to facilitate movement. Dopamine D2 receptors (D2+)
are expressed on indirect pathway MSNs that inhibit movement
initiation.
Proper motor control relies on a complex balance of D1+ and
D2+ MSN excitation. Further, MSN excitability and synchrony
is thought to be altered in dopamine-depleted animal models of
Parkinson’s disease (Costa et al., 2006; Fino et al., 2007;Azdad et al.,
2009; Burkhardt et al., 2009; Jáidar et al., 2010). Although overly
simpliﬁed, it is thought that D2+ MSNs experience increased
excitability in the disease state (Day et al., 2006, 2008; Mallet et al.,
2006; Shen et al.,2007;Tian et al.,2010),whileD1+MSNs show lit-
tle changes (Day et al., 2006; Tian et al., 2010). Indeed, optogenetic
activation of striatal D2+ MSNs in vivo mimicked Parkinson’s
disease with decreased movement initiation and increased freez-
ing behavior (Kravitz et al., 2010). Thus, the intrinsic mechanisms
that control MSN output are of crucial interest in understanding
the underlying factors that mediate altered neuronal excitability.
GABAergic inhibition is mediated by a combination of fast,
phasic inhibition and a slower, tonic inhibition. Synaptic release of
neurotransmitter mediates phasic inhibition through low-afﬁnity
synaptic GABAA receptors and is effective in generating neuronal
rhythmic activity and synchronicity (Cobb et al., 1995). Tonic inhi-
bition, due to GABA spillover, is mediated through high-afﬁnity
receptors located in the extrasynaptic space, and increases a cell’s
input conductance, affecting neuronal excitability (Brickley et al.,
1996). Therefore, the subunits that mediate striatal MSN tonic
inhibition are of crucial interest in understanding the underlying
factors that control MSN output and altered neuronal excitabil-
ity. Our previous study used pharmacology to identify the GABAA
receptor β3 subunit as an important regulator of both striatal D1+
and D2+ MSN tonic current (Janssen et al., 2009).
In general,β3 subunit knock-out (KO)mice show an increase in
seizure activity and serve as an animal model for Angelman’s syn-
drome (DeLorey et al., 1998). Studies from global β3 subunit KO
mice have illustrated the subunit’s importance in synaptic trans-
mission and oscillatory behavior or synchronicity (Huntsman
et al., 1999; Nusser et al., 2001; Hentschke et al., 2009). Corti-
cal cultures from β3 subunit KO animals further showed that this
subunit is crucial for synaptic inhibition (Ramadan et al., 2003).
To our knowledge, no study has investigated the role of the β3
subunit in striatal inhibition using a genetic approach. Therefore,
we investigated the role of β3 GABAA receptor subunits on striatal
MSN phasic and tonic currents by selectively excising the subunit
from D2-expressing neurons (Drd2-Cre; Gong et al., 2007; i.e.,
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striatal D2+MSNs) using theCre-lox system. This conditional KO
approach allowed us to more accurately determine the importance
of this subunit without more global compensatory mechanisms.
We found that the β3 GABAA receptor subunit is fundamen-
tal in both phasic and tonic inhibition as miniature inhibitory
post-synaptic current (mIPSC) decay kinetics and tonic current
were signiﬁcantly altered in conditional KO animals. In addition,
deletion of this subunit signiﬁcantly decreased the excitability
of MSNs, suggesting the GABAA receptor β3 subunit may be
an important pharmacological target in the treatment of striatal
disorders.
MATERIALS AND METHODS
ANIMALS
Bacterial artiﬁcial chromosome (BAC) mice that identify the indi-
rect striatal output pathway (BAC-D2-EGFP; Gong et al., 2003)
were crossed with BAC mice that identify the direct striatal output
pathway (Drd1a-tdTomato; Shuen et al., 2008) so progeny (BAC-
D2-EGFP; Drd1a-tdTomato) contained ﬂuorescent markers for
simultaneous visualization of both indirect and direct pathways.
Conditional β3 subunit knock-out (KO) mice were produced
by crossing ﬂoxed β3 mice (β3f/f; Jackson Labs #008310; Fer-
guson et al., 2007) with transgenic mice that expressed Cre
recombinase under the Drd2 promoter (GENSAT, ER44; Gong
et al., 2007) to yield β3f/+Drd2 mice. These mice were then
crossed with β3f/f mice to generate β3f/f, β3f/+Drd2, and β3f/fDrd2
mice. To determine the integrity of the Drd2-Cre expression,
Drd2-Cre mice were crossed with a Cre reporter mouse express-
ing tdTomato (ROSA-tdTomato, Jackson Labs #007914; Madisen
et al., 2010). Parvalbumin-expressing interneurons (zolpidem
control experiments) were identiﬁed by a cross between Parv-
Cre (Jackson Labs #008069; Murray et al., 2011) and ROSA-
tdTomato reporter mice. All mice were genotyped through stan-
dard PCR procedures. The following primers were used to
genotype tail DNA: Cre – F5′-GGATGAGGTTCGCAAGAACC-
3′, R5′-CCATGAGTGAACGAACCTGG-3′ with a PCR product
at 400 bp; Floxedβ3 – F5′-ATTCGCCTGAGACCCGACT-3′, R5′-
GTTCATCCCCACGCAGAC-3′ with PCR products of ∼250 bp
for wild-type β3 subunit allele and∼300 bp for the ﬂoxedβ3 allele.
IMMUNOHISTOCHEMISTRY
Progeny of mouse matings between Drd2-Cre and ROSA-
tdTomato reporter mice were used to assess the ﬁdelity of the
Drd2-Cre expression. Whole mouse brains (∼18 days) were ﬁxed
and coronally sliced at 100μm using a Lancer Vibratome (Series
1000, Sherwood Medical, St. Louis, MO, USA). Free-ﬂoating tis-
sue sections were blocked with 4% normal donkey serum in PBS
for 1 h at room temperature and washed for 30min in PBS/0.1%
Triton-X100 (Tx). Rabbit α-DARPP-32 (19A3, Cell Signaling) 1˚
antibody (1:200) was diluted in PBS/Tx/1% BSA and slices were
incubated at room temperature for approximately 18 h. Slices were
washed for 30min in PBS/Tx. Goat α-rabbit 2˚ antibody con-
jugated to FITC (Invitrogen, Carlsbad, CA, USA) was diluted
1:500 in PBS/Tx/BSA and exposed to tissue for 1.5 h at room
temperature. The 2˚ antibody was washed with PBS/Tx, and
sectionswere placed onmicroscope slideswithVECTASHIELDH-
1000 mounting media (Vector Labs, Burlingame, CA, USA) and
sealed with glass coverslips. For imaging, a Nikon Eclipse E600
microscope (Nikon Instruments, Melville, NY, USA) was used
to excite endogenous tdTomato and FITC ﬂuorophores. Colocal-
ization of immunostaining was performed by manually tracing
regions of interest corresponding to cell bodies of tdTomato+
neurons and/or FITC+ neurons using MetaMorph software
(Molecular Devices).
WESTERN BLOTS
Striata and cortex were dissected from 7 β3f/+ and β3f/f (Cre−)
and 6 β3f/fDrd2 (Cre+) adult mice (>30 days) and ﬂash-frozen
on dry ice. Tissue homogenates were prepared in TEE buffer
containing (in mM): Tris-HCl (10), pH 7.4, EDTA (1) and (1),
centrifuged (30,000×g ) and crude membrane pellets were resus-
pended. Each sample was diluted down to a protein concentration
of 1μg/μL in TEE buffer. Equivalent amounts of protein (10μg)
were run on a sodium dodecyl sulfate-polyacrylamide gel (10%
polyacrylamide) and transferred to the polyscreen polyvinylidene
ﬂuoride (New England Nuclear, Boston, MA, USA) membranes
in transfer buffer containing (in mM): Tris-HCl (25), glycine
(192), 20% methanol. Blots were blocked in PBST buffer con-
taining (in mM): NaPO4 (10), pH 7.4, NaCl (140), and 0.1% v/v
Tween (20) containing 1% bovine serum albumin (Sigma) and
incubated with α-β3 antibody (1:1000; NB300-119; Novus Bio-
logicals, Littleton, CO, USA) overnight at 4˚C. Blots were then
washed with PBST buffer and incubated with α-rabbit horserad-
ish peroxidase antibody (1:5000; Amersham, Piscataway,NJ,USA)
for 30min at room temperature. After several washes, individual
bands were visualized on Hyperﬁlm (Amersham, Piscataway, NJ,
USA) with enhanced chemiluminescence SuperSignal West Pico
Enhancer Solution (Pierce, Rockford, IL, USA). Membranes were
stripped of all antibodies for 1 h in elution buffer and incubated in
α-β-actin antibody (Sigma) overnight at 4˚C. Films were scanned
and quantiﬁed using ImageJ software (http://rsb.info.nih.gov/ij/).
SLICE PREPARATION
Young male and female mice (15–23 days) were sacriﬁced by
decapitation in agreement with the guidelines of the AMVA Panel
on Euthanasia and the Georgetown University ACUC. Adult ani-
mals (>30 days) were used in some experiments,where noted. The
whole brain was removed and placed in an ice-cold slicing solu-
tion containing (in mM): NaCl (85), KCl (2.5), CaCl2 (1), MgCl2
(4), NaH2PO4 (1), NaHCO3 (25), glucose (25), sucrose (75; all
from Sigma). Corticostriatal coronal slices (250μm) were pre-
pared using aVibratome 3000 Plus Sectioning System (Vibratome,
St Louis, MO, USA) in slicing solution. They were incubated in
artiﬁcial cerebrospinal ﬂuid (aCSF) containing (in mM): NaCl
(124), KCl (4.5), Na2HPO4 (1.2), NaHCO3 (26), CaCl2 (2.0),
MgCl2 (1), and dextrose (10.0) at 305mOsm at 32˚C for 30min.
Slices recovered for an additional 30min in aCSF, at room tem-
perature, 22–24˚C. All solutions were maintained at pH 7.4 by
continuous bubbling with 95% O2, 5% CO2.
Slices were visualized under an upright microscope (E600FN,
Nikon) equipped with Nomarski optics and an electrically insu-
lated 60× water immersion objective with a long working distance
(2mm) and high numerical aperture (1.0). Recording pipettes
were pulled on a vertical pipette puller from borosilicate glass
capillaries (Wiretrol II; Drummond) and ﬁlled with cesium
chloride (CsCl)- or potassium gluconate (Kgluc)-based internal
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solutions. The CsCl-based internal solution contained (in mM):
CsCl (145), HEPES (10), ATP–Mg (5), GTP–Na (0.2), EGTA (10),
adjusted to pH 7.2 with CsOH. This high chloride internal solu-
tion enhanced the detection of GABAergic events, placing their
reversal potential near 0mV. In Kgluc-based internal solutions,
CsCl was replaced with equimolar (145mM) K gluconate and pH
was adjusted with KOH. Kgluc internal solutions did not alter the
chloride concentration and the reversal potential for GABAergic
events was around −60mV.
WHOLE-CELL RECORDINGS
In BAC-D2-EGFP;Drd1a-tdTomato mice,MSNs were classiﬁed as
being either striatopallidal dopamine D2 receptor positive (D2+)
or striatonigral dopamine D1 receptor positive (D1+) based on
their expression of EGFP and tdTomato, respectively. In β3 subunit
transgenic mice, MSNs were not tagged with ﬂuorescent proteins
(to blind the study), so the sample population likely contains both
D1+ and D2+ MSNs.
All recordings were performed at room temperature, 22–24˚C.
Voltage-clamp recordings were achieved using the whole-cell con-
ﬁguration of the patch-clamp technique at a holding voltage of
−60mV using the Axopatch 200B ampliﬁer (Molecular Device
Co., Sunnyvale, CA, USA). Access resistance was monitored dur-
ing the recordings and experiments with >20% change were
discarded. When Kgluc internal solutions were used, the base-
line membrane potential for current-clamp recordings was set at
−70mV before each series of current step injection protocols.
Rheobase current was deﬁned as the ﬁrst current step, within a
series of 20 pA steps, that elicited an action potential. Recordings
were not corrected for liquid junction potential.
Stock solutions of bicuculline methobromide (BMR), GABA
(both from Sigma), and tetrodotoxin (TTX; Alomone Labs) were
prepared in water. Etomidate, zolpidem,ﬂumazenil, and diazepam
(Sigma) were dissolved in dimethylsulfoxide (<0.01% ﬁnal con-
centration). All stock solutions were diluted to the desired con-
centration in aCSF and applied locally through a Y tube (Murase
et al., 1989) modiﬁed for optimal solution exchange in brain slices
(Hevers and Lüddens, 2002).
Currents were ﬁltered at 2 kHz with a low-pass Bessel ﬁlter
and digitized at 5–10 kHz using a personal computer equipped
with Digidata 1322A data acquisition board and pCLAMP10
software (both from Molecular Devices). Off-line data analysis,
curve ﬁtting, and ﬁgure preparation were performed with Clamp-
ﬁt10 software (Molecular Devices). Spontaneous and miniature
inhibitory post-synaptic currents (sIPSCs andmIPSCs)were iden-
tiﬁed using a semi-automated threshold-based mini detection
software (Mini Analysis, Synaptosoft Inc., Fort Lee, NJ, USA) and
were visually conﬁrmed. IPSC averages were based on more than
50 non-overlapping events, and decay kinetics were determined
with averaged IPSC traces using double exponential curve ﬁttings
and reported as weighted time constants (Tw):
Tw = τ1 × A1/ (A1 + A2) + τ2 × A2/ (A1 + A2)
where τx is the decay time constant for a particular com-
ponent of the curve and Ax is the peak amplitude of the
corresponding component. All detected events were used for event
frequency analysis, but superimposing events were eliminated for
the amplitude and decay kinetic analysis.
Tonic current was primarily measured with an all-points his-
togram that measured the mean holding current 10 s before and
during BMR application (Janssen et al., 2009). Tonic current is
represented as the change in baseline amplitude. When indicated,
tonic current was also measured by changes in RMS noise before
and during BMR application (Glykys and Mody, 2007). These
analyses were based on an all-points histogram that was ﬁtted to
the Gaussian function (Fleming et al., 2007):
(x) = A • exp [− (x − μ)2 /2σ 2]
where σ represents the RMS noise during the 10 s period before
and during drug application and μ represents the mean holding
current. Tonic noise was measured as a difference in RMS noise
between two conditions.
STATISTICS
Box and whisker plots were generated for more accurate repre-
sentation of critical data. The whiskers include the minimum
and maximum values, while the box outlines the 25th and 75th
percentile of data points. The median value is represented by a
bar inside the box. Scatterplots of individual data points are also
included in these plots to further show data spread.
Cumulative probability plots were constructed by averaging the
single cell probability distribution, as calculated in Mini Analysis,
for amplitudes and frequencies across all cells. Dotted lines denote
the SEM for the data set.
Statistical signiﬁcance was determined using the paired two-
tailed Student’s t -test to compare pre-drug conditionswith record-
ings made under drug conditions of the same cell population.
Unpaired two-tailed Student’s t -test was used for comparisons
across cell groups as well as for comparisons of striata and cortex
from β3f/+ and β3f/f (Cre−) and β3f/fDrd2 (Cre+) mice for β3
subunit and actin protein in Western blots. Signiﬁcance criteria
was set at p < 0.05, and all values in text and ﬁgures are expressed
as mean± SEM. In text and ﬁgures, ∗p < 0.05, ∗∗p < 0.005, and
∗∗∗p < 0.0005, unless noted otherwise.
RESULTS
GENERATION OF THE CONDITIONAL β3 GABAA RECEPTOR SUBUNIT
KNOCK-OUT IN D2+MSNs
To study the role of the β3GABAA receptor subunit in striatalMSN
tonic current, the subunitwas renderednon-functional by deleting
exon 3 (Ferguson et al., 2007). We deleted this sequence by cross-
ing ﬂoxed β3 subunit (β3f/f) mice with Drd2-Cre mice, where Cre
recombinase is selectively expressed indopamine receptor 2 (D2+)
neurons.β3f/fDrd2 mice had theβ3 subunit selectively deleted from
all Drd2-expressing neurons, while β3f/+Drd2 and β3f/f mice had
the incomplete combination of alleles and served as controls.
To verify the integrity of Drd2-Cre expression, we crossed
this animal with a ROSA-tdTomato reporter mouse; any cell that
expresses Cre recombinase will also express tdTomato. Counter-
staining to DARPP-32 (a general marker for MSNs) showed that
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all tdTomato+ cells were also DARPP-32+ (Figure 1A). Further,
approximately half of the DARPP-32+ cells were also positive
for tdTomato, consistent with previous reports that show simi-
lar numbers of striatal D2+ and D1+ MSNs (Shuen et al., 2008).
The adjacent cortex showed minimal tdTomato and DARPP-32
expression (data not shown).
To examine the degree to which the β3 subunit was reduced in
the striatum of β3f/fDrd2 mice, western blot analysis of cortex and
striatumwereperformedusing an antibody speciﬁc for theGABAA
receptor β3 subunit (Figures 1B–D). As shown in Figure 1B, β3
subunit protein was signiﬁcantly reduced in striatum of Cre pos-
itive mice compared to Cre negative controls (31% reduction).
This reduction was expected as striatal D2+ MSNs constitute
approximately half of the striatal MSN population (Shuen et al.,
2008; personal observations). Since the cortex does not contain
Drd2-expressing neurons, it serves as an ideal control. Indeed, β3
subunit protein levels were not reduced in cortical tissue from Cre
positive mice (Figure 1C).
To investigate the consequences of β3 GABAA receptor subunit
ablation in Drd2-expressing neurons, we ﬁrst examined whether
this deletion was affecting litter size. The ﬂoxed β3 GABAA recep-
tor subunit mice were originally developed (Ferguson et al., 2007)
to avoid neonatal lethality associated with global knock-out (KO)
of the β3 subunit (Homanics et al., 1997). To determine whether
our conditional KO animals experienced enhanced lethality, the
number of β3f/+Drd2 mice surviving to p7 was compared to
the number of β3f/fDrd2mice from several litters. The ratio of
β3f/+Drd2 to β3f/fDrd2 mice was similar to the 1:1 ratio (n = 10)
FIGURE 1 | Striatal β3 subunit protein reduced conditional KO mice.
(A) Fluorescent images demonstrating colocalization between endogenous
tdTomato ﬂuorescence and DARPP-32 expression. Approximately half of the
DARPP-32+ cells expressed endogenous tdTomato, indicative of Cre
expression. Scale bar is 25μm. (B) Representative western blot analysis
of the GABAA receptor β3 subunit from individual 30-day-old mice
revealed reduced amounts of β3 subunit protein in striatum (B) from
Cre positive (β3f/fDrd2) animals compared to Cre negative (β3f/+ and β3f/f)
control animals. The amount of β3 protein in cortex (C) did not differ
between genotypes. Blots were reprobed for β-actin. (D) Summary graph of
western blot analysis demonstrating a signiﬁcant reduction in β3 protein in
striatum, but not cortex. Data are expressed as percent change in band
intensity relative to Cre negative controls following normalization to
actin.
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predicted by Mendelian genetics with our breeding scheme, sug-
gesting that β3f/fDrd2 mice do not experience premature death. All
mice lacked any abnormal phenotypes like cleft palate or hyperac-
tivity, which were observed in global β3 subunit KOs (Homanics
et al., 1997), but not pan-neuronal KOs (Ferguson et al., 2007).
Under general observation,β3f/fDrd2 animals did not display gross
behavioral abnormalities compared to control littermates. Further
tests need to be conducted to determine more subtle behavioral
abnormalities.
CONDITIONAL β3 SUBUNIT KO MICE LACK TYPICAL MSN TONIC
CURRENT EXPRESSION PATTERN
Because our previous work suggested that striatal MSN GABAer-
gic tonic current may be mediated (at least in part) through the
β3 GABAA receptor subunit (Janssen et al., 2009), it was impor-
tant to determine MSN tonic current expression patterns in these
conditional β3 subunit KO mice. Although dopamine receptor
expression was not identiﬁed,many cells were sampled, and there-
fore the sample population likely contains both D1+ and D2+
MSNs. Because cell identity was not known, box and whisker plots
are presented to demonstrate the tonic current expression spread
and pattern. Averages were used to determine signiﬁcance in these
cells.
Striatal MSN GABAergic tonic inhibition was measured and
compared between wild-type BAC-D2-EGFP; Drd1a-tdTomato
mice, β3f/f, β3f/+Drd2, and β3f/fDrd2 mice to verify that any dif-
ferences observed in tonic current were due to the lack of the
β3 subunit. It is possible that the ﬂoxed β3 allele alters β3 sub-
unit function, also affecting tonic current expression in neurons.
Therefore, MSN GABA-mediated tonic currents were measured
from mice that lacked Cre recombinase expression, but were
homozygous for the ﬂoxed β3 allele (β3f/f). Suggesting inclu-
sion of unaltered D1+ and D2+ MSNs in the sample population,
β3f/f mice showed quite varied tonic current amplitudes (0–34 pA;
Figure 2B), similar to the varied tonic current amplitudes in BAC-
D2-EGFP; Drd1a-tdTomato wild-type mice (Figure 2B, right).
These functional data support western blot analysis which sug-
gested that β3 subunits are not affected by the inclusion of loxP
sites (Figure 1B; Ferguson et al., 2007). Further, the presence of
the wide box representing the 25th and 75th percentile, shown
in Figure 2B, shows a high degree of variability in tonic current
amplitudes (0–25 pA, n = 14) from striatal MSNs in β3f/+Drd2
mice. On the other hand, β3f/fDrd2 mice had tonic current ampli-
tudes that were conﬁned to a much more narrow range (0–10 pA,
n = 29). The averageGABA-mediated tonic current amplitudewas
signiﬁcantly smaller in conditional β3 subunit KO mice compared
to both types of control mice (β3f/fDrd2: 3.1± 0.5 pA, n = 29;
β3f/f: 11.3± 2.7 pA, n = 13, p < 0.0005; β3f/+Drd2: 11.0± 2.3 pA,
n = 14,p < 0.0005). In addition,RMSnoisewas signiﬁcantly lower
in β3f/fDrd2 mice (0.8± 0.1 pA, n = 24) compared to β3f/+Drd2
(1.4± 0.2 pA,n = 14; p < 0.05) and β3f/f littermates (1.9± 0.5 pA,
n = 11,p < 0.005). Because results from these two controlmice did
not differ, the data were pooled for Figures 3–5 (although labeled
in text and ﬁgures as β3f/f for clarity). Since allMSNs in the sample
population showed little to no tonic current, these results suggest
D2+ MSN tonic current expression is largely dependent upon β3
subunit expression.
FIGURE 2 | Conditional β3 subunit KO mice show reduced
GABA-mediated tonic current in MSNs. (A) Individual representative
current traces displaying MSN BMR-sensitive (25μM) tonic current in
control β3f/f mice (left) and β3f/fDrd2 mice (right). The dichotomous pattern of
tonic current was not present in β3f/fDrd2 mice. (B) Summary box and
whisker plots displaying the tonic current patterns in β3f/f (open square,
left; n =13), β3f/+Drd2 (open square, middle; n =14), β3f/fDrd2 (black square,
middle; n =29), and wild-type BAC-D2-EGFP;Drd1a-tdTomato D1+ (light
gray, right n =15) and D2+ (dark gray, right n =10) MSNs from at least
three mice in each group. (C) Summary box and whisker plots displaying
the tonic current patterns in adult β3f/f (open square, left; n =12), β3f/fDrd2
(black square, right; n =7) from at least three mice in each group.
Our immunohistochemistry and western blot data suggest that
theβ3 subunitwas deleted froma select groupof striatalMSNs,but
does not address the subtype. Because the MSN GABAergic tonic
current pattern shifts through development such that adult D1+
MSNs express the majority of the GABAergic tonic conductance
(Janssen et al., 2009; Santhakumar et al., 2010), we recorded tonic
current from adult β3f/fDrd2 and β3f/f mice (>30 days). Indicative
of a population of D1+ and D2+ MSNs, BMR-sensitive tonic
current from β3f/f MSNs was highly variable (0–18 pA), with
an average of 10.9± 2.0 pA (n = 12; Figure 2C). Tonic current
expression from adult β3f/fDrd2 MSNs showed a similar, variable
pattern (0–19 pA),with an average of 7.6± 2.8 pA (n = 7; p = 0.3).
Both data sets were signiﬁcantly different from tonic current aver-
ages from young β3f/fDrd2 mice (adult β3f/f p < 0.0005; β3f/fDrd2
p < 0.05). These data further suggest that the β3 subunit was only
deleted from D2+ MSNs since adult striatal tonic current from
KO mice resembled that of the controls.
CONDITIONAL DELETION OF β3 SUBUNIT ALTERS MSN ETOMIDATE
AND GABA RESPONSE
To functionally verify that the β3 subunit was successfully excised
from striatal D2+ MSNs, the effects of etomidate in TTX were
tested on β3f/f (and β3f/+Drd2 with pooled data) and β3f/fDrd2
mice. This general anesthetic is a selective pharmacological agent
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FIGURE 3 | β3 GABAA receptor subunit affects GABA sensitivity. (A)
Representative traces of etomidate (3μM) responses in TTX (0.5μM) from
β3f/f (top) and β3f/fDrd2 (bottom) mice. (B) Summary box and whisker plots
showing effects of etomidate in TTX from 3 β3f/f (open square; n =17), 5
β3f/fDrd2 (black; n =15), and 6 BAC-Drd2-EGFP; Drd1a-tdTomato mice with
D1+ (light gray; n =12) and D2+ (dark gray; n =12) neurons. (C)
Representative traces of GABA (1μM) responses inTTX (0.5μM) from β3f/f
(top) and β3f/fDrd2 (bottom) mice. (D) Summary box and whisker plots
showing effects of GABA in TTX from 5 β3f/f (open square; n =15), 3
β3f/fDrd2 (black; n =6), and 6 wild-type BAC-D2-EGFP; Drd1a-tdTomato mice
from D1+ (light gray; n =10) and D2+ (dark gray; n =11) neurons.
at β2/3-containing GABAA receptors (Hill-Venning et al., 1997).
In striatal MSNs, however, etomidate identiﬁes β3 subunit-
containing GABAA receptors (Janssen et al., 2009) due to their
lack of β2 subunit expression (Flores-Hernandez et al., 2000).
Responses to etomidate (3μM) in TTX averaged 37.7± 6.8 pA
(n = 17) in β3f/f mice, with a wide range of amplitudes (1–
95 pA), suggesting that this population contains both relatively
etomidate-insensitive D1+ MSNs and etomidate-sensitive D2+
MSNs, as seen inwild-type BAC-D2-EGFP;Drd1a-tdTomatomice
(Figure 3B). The range of etomidate responses was more narrow
from β3f/fDrd2 mice (0–35 pA), and the average was signiﬁcantly
smaller (14.9± 2.7 pA,n = 15,p < 0.005;Figure 3B), andwas sim-
ilar to etomidate currents recorded from wild-type D1+ MSNs.
These data functionally conﬁrm that the β3 subunit was deleted
in etomidate-sensitive D2+ MSNs.
Post-synaptic GABA responses were also assessed in β3f/fDrd2
mice (in the presence of TTX) to determine if the β3 subunit plays
a role in the differential D1+ and D2+ MSN GABA sensitivity
(Ade et al., 2008) seen in wild-type mice. The average response
to GABA (1μM) in control β3f/f mice was 44.2± 8.5 pA (n = 15)
with a range of 1–101 pA. The wide range of GABA responses were
similar in current amplitude to identiﬁed D2+ and D1+ MSNs
from BAC-D2-EGFP; Drd1a-tdTomato mice (Figure 3D). In con-
trast, β3f/fDrd2 mice expressed an average inward GABA current
FIGURE 4 | Synaptic decay is altered in MSNs from conditional KO
mice. (A) Representative mIPSC traces from β3f/f and β3f/fDrd2 mice. (B,C)
Summary mIPSC frequency and amplitude graphs (left) and averaged
cumulative distribution plots for all cells (right) in β3f/f and β3f/fDrd2 mice. (D)
Representative individual mIPSCs (left) with double exponential decay
ﬁttings in gray from β3f/f and β3f/fDrd2 mice. Summary of decay ﬁttings,
right. Data derive from 16 to 17 cells from at least three mice in each group.
of just 14.0± 2.7 pA (n = 6, p < 0.05), with a more narrow range
of amplitudes (9–24 pA; Figure 3D). These data suggest that the
absence β3 subunit may affect GABAA receptor number and ago-
nist sensitivity at D2+ MSN receptors, as previously shown in
HEK293 cells (Janssen et al., 2009).
DELETION OF THE β3 SUBUNIT AFFECTS SYNAPTIC RECEPTOR
COMPOSITION
Although D1+ and D2+ MSNs do not differ in their mIPSC
proﬁle (Ade et al., 2008), mIPSC characteristics from unidenti-
ﬁed MSN subtypes were compared between β3f/fDrd2 and control
β3f/f mice to evaluate changes in the composition of synaptically
located GABAA receptors. As shown in Figure 4A and quantiﬁed
in Figures 4B,C and Table 1, mIPSC frequency and amplitude
did not change with β3 subunit deletion. However, mIPSC decay
kinetics from β3f/fDrd2 mice were signiﬁcantly faster than those
from β3f/f mice (Figure 4D).
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FIGURE 5 | Zolpidem fails to modulate majority of mIPSCs in MSNs from conditional KO mice. (A) Averaged representative mIPSC traces from a β3f/f
(top) and a β3f/fDrd2 (bottom) neuron with zolpidem (1μM). (B) Summary graphs showing zolpidem sensitivity on β3f/f (top) and β3f/fDrd2 (bottom) MSN kinetics
(left) and amplitude (right). Cells were determined to be responders if their mIPSC decay increased at least 110% of control. The majority of neurons from
control β3f/f mice showed a signiﬁcant mIPSC prolongation (n =15/24), while the majority of neurons from β3f/fDrd2 mice did not (n =6/9). Cells derive from at
least two mice in each group.
Table 1 | mIPSC characteristics of MSNs from β3f/f and β3f/fDrd2 mice.
mIPSC Frequency
(Hz)
mIPSCAmplitude
(pA)
mIPSCTw
(ms)
β3f/f 0.99±0.1 (n =13) 28.2±1.5 (n =13) 31.9±2.3 (n =14)
β3f/fDrd2 0.82±0.1 (n =17) 28.4±2.6 (n =17) 26.2±1.0 (n =15)*
*Denotes signiﬁcance to control β3f/f mice.
Since decreased numbers of synaptic receptors are reﬂected
by decreased mIPSC amplitude, the data presented here sug-
gest homeostatic changes of GABAA receptors at MSN inhibitory
synapses upon β3 subunit deletion. Further, the faster decay of
mIPSCs in β3f/fDrd2 animals suggests that this subunit deletion
uncovers a distinct pool of synaptic receptors and/or causes a com-
pensatory upregulation of synaptic GABAA receptors with faster
kinetic properties.
Because α subunits largely determine synaptic receptor decay
properties (Picton and Fisher, 2007), we used the imidazopyri-
dine zolpidem (1μM), effective at GABAA receptor α1–3 sub-
units, to determine GABAA receptor subunit differences between
β3f/f and β3f/fDrd2 mice (Figure 5A). Cells that displayed
decay prolongation more than 110% control were deﬁned as
“zolpidem sensitive.” Zolpidem prolonged the average mIPSC
decay kinetics in 15 of 24 (62%) neurons from β3f/f mice
(134± 5% control; Figure 5B). The remaining nine neurons
did not respond (97.9± 3% control). mIPSC potentiation in
zolpidem sensitive cells was suppressed with co-application
of the benzodiazepine antagonist ﬂumazenil (10μM), bring-
ing mIPSC decay kinetics to their original states (zolpidem:
142.3± 8% control; ﬂumazenil+ zolpidem: 107.6± 14% control,
n = 6). Flumazenil application alone failed to prolong the
kinetics of zolpidem sensitive and insensitive mIPSCs (85 ± 5%,
n = 14 and 68.9± 2%, n = 2), suggesting a minimal contribution
from α4 subunits (Wafford et al., 1996). Diazepam (5μM) pro-
longed the kinetics in all cells (sensitive: 138.4± 11%, n = 12;
insensitive: 141.5± 11%, n = 3), supporting previous ﬁndings
(Ade et al., 2008) suggesting thepresenceof α5-containing synaptic
receptors in MSNs.
Zolpidem affected fewer neurons from β3f/fDrd2 mice (three
of nine, 33%); the increased decay kinetics in these cells did not
reach signiﬁcance (124.1± 1% control; Figure 5B). Most cells (six
of nine, 67%) from β3f/fDrd2 mice showed no response to zolpi-
dem application (100.6± 5% control). Therefore, zolpidem failed
to affect the majority of MSNs from β3f/fDrd2 mice, suggesting the
upregulation of a zolpidem-insensitive α subunit.
To test the sensitivity of zolpidem on a cell-type that is known
to express an abundance of synaptic α1-containing GABAA recep-
tors, we recorded from parvalbumin- (PV+) expressing striatal
interneurons (Riedel et al., 1998). The PV+ interneuron mIPSC
decay was faster (15.9± 1.5ms, n = 4) than MSNs, and was pro-
longed 221.7± 50% control with zolpidem (1μM) application.
β3 SUBUNIT RESPONSIBLE FOR DIFFERENCES IN EXCITABILITY
BETWEEN D1+ AND D2+MSNs
Our previous work suggested that GABA-mediated tonic current
affects striatal MSN excitability (Ade et al., 2008; Janssen et al.,
2009), and therefore it is possible that by modulating GABAergic
tonic current, β3 subunit expression also contributes to differ-
ences in D1+ and D2+ MSN excitability (Ade et al., 2008; Cepeda
et al., 2008; Gertler et al., 2008; Janssen et al., 2009). Thus, we
compared MSN excitability in identiﬁed D1+ and D2+ MSNs in
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BAC-D2-EGFP; Drd1a-tdTomato mice to MSNs from β3f/fDrd2
mice. For these experiments, a Kgluc-based internal solution
was used with the current-clamp technique. Cells were held at
a pre-determined membrane potential (−70mV), and subjected
to 1 s, 20 pA steps of hyperpolarizing and depolarizing current
injections.
As previously shown (Ade et al., 2008; Janssen et al., 2009),
D2+ MSNs were signiﬁcantly more excitable than D1+ MSNs
(Figure 6). A substantial MSN sample size from β3f/fDrd2 mice
showed that these cells were signiﬁcantly less excitable than wild-
type MSNs (Figure 6). The input–output curves and rheobase
measurements from this mutant mouse were similar to wild-type
D1+ MSNs and support the ﬁnding that the β3 GABAA receptor
subunit regulates and contributes to the increased excitability of
striatal D2+ MSNs.
DISCUSSION
Pharmacological evidence suggested that β3 GABAA receptor sub-
units contribute to differences in GABA-mediated tonic currents
between D2+ and D1+ MSNs (Janssen et al., 2009). The present
study sought to complement and conﬁrm those results with a
FIGURE 6 | β3 subunit determines cell excitability. (A) Representative
current-clamp recordings from a D1+ MSN (left), D2+ MSN (middle),
β3f/fDrd2 MSN (right), illustrating the responses to a series of depolarizing
current injections (20 pA steps) from a set potential of −70mV. (B)
Summary of action potential ﬁring frequency in response to increasing
depolarizing current injections in D1+ (n =10), D2+ (n =9), and β3f/fDrd2
(n =10) MSNs. * Denotes p <0.05 and † denotes p <0.005 for clarity. (C)
Summary graph showing the averaged rheobase current in D1+, D2+, and
β3f/fDrd2 MSNs. Data derive from the same cells in (B), from at least three
mice in each group.
genetic approach: the β3 subunit was conditionally removed from
Drd2-expressing neurons using the Cre-lox system (β3f/fDrd2).
Western blot data and etomidate-mediated currents from
β3f/fDrd2 mice veriﬁed that the β3 subunit was reduced in a sub-
population, presumably D2+, of MSNs. The most signiﬁcant, yet
anticipated, ﬁnding with β3f/fDrd2 mice was the dramatic reduc-
tion in tonic current amplitude and spread, a consequence of
GABAA receptor β3 subunits deletion in D2+ MSNs.
β3f/fDrd2 mice also showed substantially less GABA-mediated
inward currents in response to exogenous GABA application
than β3f/f littermates. Therefore, it is likely that high-afﬁnity β3
subunit-containing GABAA receptors contribute to the greater
GABA-sensitivity of D2+ MSNs (Ade et al., 2008). This reduced
GABA sensitivity may be due to a reduction of highly sensitive
α5β3-containing extrasynaptic receptors (Homanics et al., 1997;
Ade et al., 2008).
Synaptic current properties in β3f/fDrd2 MSNs suggest that β3
subunit deletion affects α subunit composition; receptors with
faster decay kinetics were uncovered or upregulated. Previous
studies of IPSCs in distinct neuronal populations from β3 subunit
KO mice (Huntsman et al., 1999; Ramadan et al., 2003; Hentschke
et al., 2009) showed stronger changes in IPSCs than observed
here. Faster decay and increased zolpidem sensitivity of mIPSCs in
cortical neurons of primary cultures fromβ3 subunitKOmice sug-
gested that the β3 subunit preferentially assembles with α2/3 sub-
units (Ramadan et al., 2003) with slower decay properties, as has
been shown through immunoprecipitation (Benke et al., 1994).
It has been hypothesized that removal of the β3 subunit leaves
α1β2 subunit-containing synaptic receptors with faster decay and
greater zolpidem sensitivity (Ramadan et al., 2003). All available
data,however, suggestβ3 subunit-containingGABAA receptors are
characterized by slow synaptic decay (Figure 4; Huntsman et al.,
1999; Ramadan et al., 2003; Hentschke et al., 2009).
We previously showed that MSN synaptic receptors do not dif-
fer between D1+ and D2+ MSNs, are comprised of α2 and α5
subunits, and are slightly sensitive to zolpidem (Ade et al., 2008).
As zolpidem had no effect on the majority of rapidly decaying
mIPSCs from β3f/fDrd2 mice, we suggest that deletion of the β3
subunit uncovered or upregulated synaptic receptors that con-
tain the α4 or α5 subunit, characterized by faster decay kinetics
than those with α2 or α1 subunits (Picton and Fisher, 2007). It is
plausible that removal of the β3 subunit uncovers or upregulates
α4/5β1-containing synaptic receptors since the β2 subunit is not
expressed in MSNs (Flores-Hernandez et al., 2000).
Our data also support a homeostatic upregulation of GABAA
receptors upon β3 subunit deletion since mIPSC amplitude
remained unchanged. A select population of sIPSCs in the hip-
pocampusof β3 subunitKOmice also showedunaltered amplitude
with faster decay although receptor upregulation was not specif-
ically investigated (Hentschke et al., 2009). Yet, it appears that
β3 subunit deletion does not result in receptor upregulation in
many brain regions (Homanics et al., 1997; Huntsman et al.,
1999; Nusser et al., 2001; Wong et al., 2001; Ramadan et al., 2003;
Ferguson et al., 2007). Receptor upregulation may occur in the
striatum following β3 subunit deletion because receptor compo-
sition is highly dependent upon the abundance of both β1 and β3
subunits.
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MSN excitability was signiﬁcantly lower in MSNs from
β3f/fDrd2 mice, suggesting that D2+ MSN output was decreased
to levels that are normally characteristic of D1+ MSNs. This data
indicates that disruption of β3 subunit expression, and therefore
MSN GABAA-mediated tonic current, signiﬁcantly affects MSN
output, as previously reported and discussed (Ade et al., 2008;
Janssen et al., 2009).
This study veriﬁes that D2+ MSN tonic current is mediated
through the β3 GABAA receptor subunit, but offers no direct indi-
cation that the subunit plays an essential role in D1+ MSN current
since the subunit was selectively deleted from D2+ MSNs. How-
ever, our previous study suggested that the β3 subunit was also
essential in modulating D1+ MSN tonic current in both young
and adult animals. Because tonic current from both cell-types
could be pharmacologically modulated with similar conditions,
the β3 subunit may mediate tonic current in both D1+ and D2+
MSNs, albeit in different situations and developmental stages.
This study primarily focuses on GABA-mediated tonic cur-
rent in young mice, yet it is important to note the developmental
changes in GABAA receptor composition (Laurie et al., 1992) and
their potential impact on striatal MSN tonic current. The devel-
opmental regulation of tonic current is clearly demonstrated by
the shifts observed in MSN tonic current patterns (Janssen et al.,
2009; Santhakumar et al., 2010). The α5 subunit mediates tonic
current in young D2+ MSNs (Ade et al., 2008), but pharmaco-
logical manipulation of this subunit did not affect D1+ or D2+
MSN tonic current in adult mice (Santhakumar et al., 2010). On
the other hand, the δ subunit has only been found to mediate
striatal tonic current in adult animals (Janssen et al., 2009; San-
thakumar et al., 2010). mRNA expression studies have shown that
young striatal tissue primarily expressesα2,α5,β3, and γXGABAA
receptor subunits, while adult tissue abundantly expresses α2, α4,
β3, and δ subunits (Laurie et al., 1992). Importantly, striatal β
subunit expression remains relatively intact throughout striatal
development, although it is more developmentally regulated in
other brain regions (Laurie et al., 1992). Based on the available
data, MSN tonic current in the young animal is predominately
mediated through α5β3γ2 receptors, while tonic current in older
MSNs is likely mediated through αXβ3δ receptors.
Many studies have noted the crucial importance of the GABAA
receptor β3 subunit; this subunit has been linked to many autism
spectrum disorders (Buxbaum et al., 2002) and childhood absence
epilepsy (Feucht et al., 1999;Urak et al., 2006).Although themech-
anism that links the β3 subunit with these developmental disorders
is unknown, the data presented here suggest that the GABAA
receptor β3 subunit largely regulates both phasic and tonic striatal
GABAergic inhibitory currents and neuronal output, a plausible
target mechanism for some aspects of these disorders. Our data
also provide signiﬁcant insight into the etiology and treatment of
movement disorders like Parkinson’s disease that manifest due to
the imbalance of output from D2+ and D1+ MSNs. Pharmaco-
logical manipulation aimed at the β3 subunit may restore proper
MSN output and alleviate movement disturbances.
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